Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Liver transplantation for alcohol-associated hepatitis.
Durkin C, Bittermann T. Durkin C, et al. Curr Opin Organ Transplant. 2023 Apr 1;28(2):85-94. doi: 10.1097/MOT.0000000000001044. Epub 2022 Dec 23. Curr Opin Organ Transplant. 2023. PMID: 36512482 Free PMC article. Review.
Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma.
Parikh ND, Mehta N, Hoteit MA, Yang JD, John BV, Moon AM, Salgia RJ, Pillai A, Kassab I, Saeed N, Thyssen E, Nathani P, McKinney J, Chan W, Durkin C, Connor M, Alsudaney M, Konjeti R, Durand B, Nissen NN, Kim HP, Paknikar R, Rich NE, Schipper MJ, Singal AG. Parikh ND, et al. Among authors: durkin c. Cancer. 2022 Oct 1;128(19):3470-3478. doi: 10.1002/cncr.34378. Epub 2022 Jul 7. Cancer. 2022. PMID: 35796530 Free PMC article.
Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective.
Kaplan DE, Serper M, Kaushik A, Durkin C, Raad A, El-Moustaid F, Smith N, Yehoshua A. Kaplan DE, et al. Among authors: durkin c. J Manag Care Spec Pharm. 2022 Oct;28(10):1138-1148. doi: 10.18553/jmcp.2022.28.10.1138. J Manag Care Spec Pharm. 2022. PMID: 36125059 Free PMC article.
BACKGROUND: Direct-acting antivirals (DAAs) have been a breakthrough therapeutic innovation in the treatment of chronic hepatitis C virus (HCV) with significantly improved efficacy, safety, and tolerability. OBJECTIVE: To evaluate the cost-effectiveness of treating patient …
BACKGROUND: Direct-acting antivirals (DAAs) have been a breakthrough therapeutic innovation in the treatment of chronic hepatitis C v …
83 results